MARKET

ERNA

ERNA

Eterna Therapeutics Inc
NASDAQ
1.855
+0.145
+8.48%
After Hours: 1.770 -0.085 -4.58% 16:00 05/03 EDT
OPEN
1.720
PREV CLOSE
1.710
HIGH
2.000
LOW
1.720
VOLUME
11.00K
TURNOVER
0
52 WEEK HIGH
3.450
52 WEEK LOW
0.8401
MARKET CAP
10.04M
P/E (TTM)
-0.4546
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ERNA last week (0422-0426)?
Weekly Report · 5d ago
Weekly Report: what happened at ERNA last week (0415-0419)?
Weekly Report · 04/22 10:29
Weekly Report: what happened at ERNA last week (0408-0412)?
Weekly Report · 04/15 10:23
Weekly Report: what happened at ERNA last week (0401-0405)?
Weekly Report · 04/08 10:26
Weekly Report: what happened at ERNA last week (0325-0329)?
Weekly Report · 04/01 10:25
Weekly Report: what happened at ERNA last week (0318-0322)?
Weekly Report · 03/25 10:27
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 03/24 12:01
Weekly Report: what happened at ERNA last week (0311-0315)?
Weekly Report · 03/18 10:26
More
About ERNA
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.

Webull offers Eterna Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.